Group B Strep International
  • Home
  • About GBS
    • What Is Group B Strep? >
      • Prenatal-onset GBS Disease
      • Early-onset GBS Disease
      • Late-onset GBS Disease
      • GBS in Nonpregnant Adults
      • Maternal GBS Infections
    • How to Help Protect Your Baby >
      • How Do You Get GBS?
      • GBS Testing
      • Testing Negative
      • Subsequent Pregnancy
      • Risk Factors
    • Signs of GBS Infection
    • GBS Vaccine Efforts
  • Resources
    • GBS Awareness Materials
    • Online Learning Events >
      • GBS Community Days 2023
      • ICGBS 2022
      • ICGBS 2021
      • ICGBS 2020
      • ICGBS 2019
      • Prenatal Infection Prevention Symposium
      • POGBSD Symposium
    • Prenatal Infection Prevention Resources
    • GBS Medical Articles and Abstracts
    • GBS Parent Connection & Grief Support
  • Parent Stories
    • GBS Babies
    • Story Submission
    • Subsequent Pregnancies
    • Possible GBS Infections
    • Perinatal Infection Stories
  • WAYS TO HELP
    • Make a Donation
    • Fundraising
    • The WAVES Study
    • Campaigns & Projects
    • Awareness Calendar >
      • Group B Strep Awareness
      • Prenatal-onset GBS Disease Recognition Month
      • Prenatal Infection Prevention Month
    • Suggested Topics for Researchers
  • About Us
    • Our Mission
    • Our Board of Directors
    • Our Partners & Perinatal Health Affiliates
    • Fast Facts
    • Contact Us

Isolated acute funisitis in the absence of acute chorioamnionitis: what does it mean?

2/24/2019

 
Measurable Learning Objectives: 
At the conclusion of this presentation, participants should be able to..
  1. To identify cases of acute funisitis without chorioamnionitis
  2. To recognize that the presence of meconium is highly associated with isolated funisitis. Therefore, there may be inflammation related to meconium-associated myonecrosis causing isolated funisitis.
Presentation Slides

Picture
Tracy B. Grossman, MD, MSc
Tracy B. Grossman is a Maternal Fetal Medicine fellow in New York City. She will be completing her fellowship in July of 2019. She is a native New Yorker and has completed most of her medical training in the New York City area. She performs research focused on maternal and neonatal adverse outcomes and has a special interest in neurologic disorders of pregnancy. She plans to continue pursuing research as a Maternal Fetal Medicine specialist in the future. ​
Tracy Grossman
2/24/2019 07:22:37 pm

Please email me if you have questions [email protected]

Jamie McGregor
2/25/2019 01:16:05 pm

Thanks . Good job! 1) did you note evidence of microbial infection in either group?;2)Were there any clinical correlates in either group other than you showed? 3) did you identify the nature of the inflammatory cells? Congrats!

Tracy Grossman
2/25/2019 01:25:49 pm

Hello Jamie

We did not record presence of microbial infection - we only used pathology reports (retrospectively collected). We only looked at the clinical correlates that I showed in the powerpoint. We did not specify the inflammatory cells (do you mean like, cytokines, etc?)

Sorry to not be more helpful.

Megan
2/25/2019 07:16:33 am

I was wondering if there are any signs of these complications on the maternal side? I know some complications can change fetal movement and a full diagnosis would have to wait until placental biopsy, but with severe infection, are there any signs you've noticed in your patients as an Ob-gyn when these infections occur? Also are there any methods to prevent this?

Tracy B Grossman
2/25/2019 01:30:55 pm

It is difficult to tease out, from retrospectively looking at delivery data and notes, what maternal clinical characteristics were present, such as clinical diagnosis of chorioamnionitis. There is a lot of back and forth about what is considered chorioamnionitis, and many times (from personal experience), we treat what is assumed to be an infection because we may see fetal tachycardia and/or maternal tachycardia without a true fever. So it is difficult to tell, based on this, who actually had chorioamnionitis suspected while intrapartum. Also, meconium is something we struggle with a lot as well. We know it is a sign of fetal distress but we also know it can be a normal part of physiology and it does not always portend a poor outcome for the neonate. From my experience, we always worry a little more about fluid that is meconium stained, and are extra-vigilant about the fetal heart tracings of babies exhibiting this. But that doesn't always mean there is a poor clinical outcome. I can't think of any methods to prevent either chorionic infection (other than the ones we already employ - limiting vaginal exams after rupture of membranes, treating with antibiotics when infection is suspected, etc) or meconium. This study MAY make me even a little MORE concerned about meconium-stained fluid, especially in the background of a not-reassuring fetal heart tracing- which may make me more likely to expedite their delivery (either vaginally or by cesarean). Hope this helps!

Megan
2/26/2019 07:01:45 am

Thank you! That answers a lot for me, I appreciate your insight!

Amy Perhach
2/26/2019 07:14:14 am

Hi,
In the demographics of your study (about the 6:50 mark) the gestational age is 38-40 weeks. Is this a study that could be replicated for preterm births? Since babies are less likely to expel meconium earlier in pregnancy, (theoretically) would the presence of it then be more likely to suggest associated funisitis?


Jolie Patterson
2/26/2019 12:22:23 pm

Parent here. Is there any way to know if the meconium is there before the actual birth?? Like with a 3D ultrasound?


Comments are closed.
    Return to Main Page
    Community Perspectives
    CME Credit

    Categories

    All
    Parent Support
    Pathways Of Infection
    Prevention Through Healthy Behaviors

Join the Campaign against GBS Disease in babies!

- Make a donation
- Tell your story!
- Distribute GBS awareness brochures
- Help translate GBS information
- Send us links to articles about GBS
Make a Donation
Shop to Support

​CONNECT TO GBSI


© COPYRIGHT 2017 -
​GBSI ALL RIGHTS RESERVED.
 
Terms and Conditions 
Privacy Policy
  • Home
  • About GBS
    • What Is Group B Strep? >
      • Prenatal-onset GBS Disease
      • Early-onset GBS Disease
      • Late-onset GBS Disease
      • GBS in Nonpregnant Adults
      • Maternal GBS Infections
    • How to Help Protect Your Baby >
      • How Do You Get GBS?
      • GBS Testing
      • Testing Negative
      • Subsequent Pregnancy
      • Risk Factors
    • Signs of GBS Infection
    • GBS Vaccine Efforts
  • Resources
    • GBS Awareness Materials
    • Online Learning Events >
      • GBS Community Days 2023
      • ICGBS 2022
      • ICGBS 2021
      • ICGBS 2020
      • ICGBS 2019
      • Prenatal Infection Prevention Symposium
      • POGBSD Symposium
    • Prenatal Infection Prevention Resources
    • GBS Medical Articles and Abstracts
    • GBS Parent Connection & Grief Support
  • Parent Stories
    • GBS Babies
    • Story Submission
    • Subsequent Pregnancies
    • Possible GBS Infections
    • Perinatal Infection Stories
  • WAYS TO HELP
    • Make a Donation
    • Fundraising
    • The WAVES Study
    • Campaigns & Projects
    • Awareness Calendar >
      • Group B Strep Awareness
      • Prenatal-onset GBS Disease Recognition Month
      • Prenatal Infection Prevention Month
    • Suggested Topics for Researchers
  • About Us
    • Our Mission
    • Our Board of Directors
    • Our Partners & Perinatal Health Affiliates
    • Fast Facts
    • Contact Us